ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard In Deal To Settle Hernia Suits, Sees $184 Million 2Q Charge

By Jon Kamp Of DOW JONES NEWSWIRES Medical device maker C.R. Bard Inc. (BCR) has reached a $184 million agreement to settle most of the lawsuits involving faulty hernia repair products it started pulling from the market years ago. The company disclosed in a regulatory filing that it expects to take a charge for the settlement--$181 million after taxes--in the second quarter. Bard struck the agreement in principle with plaintiffs' law firms, and a certain number of plaintiffs need to sign off to make it official, the company said in a Securities and Exchange Commission filing late Thursday. The company faced more than 3,500 federal and state lawsuits as of April 21, according to an earlier SEC filing. The suits involve certain sizes and lots of "Composix Kugel" products Bard voluntarily recalled starting in December 2005 because a component could break, potentially leading to issues including bowel perforations. The suits generally seek damages for personal injury, Bard said. The company said the agreement in principle covers the majority of the hernia product claims. But the second-quarter charge excludes any costs associated with pending class-action suits. As of late April, Bard said none of the class actions have been certified. There were two putative class-action suits in the U.S., including one that consolidates 10 previously filed U.S. class-action suits, four in Canada, Bard said in the April SEC filing. Shares of the Murray Hill, N.J., company rose 70 cents to $109.86 Thursday and were unchanged after hours. -By Jon Kamp, Dow Jones Newswires; 617-654-6728;

Stock News for Bard C R (BCR)
10/21/201609:01:33Current Report Filing (8-k)
10/12/201616:15:00Bard Declares Quarterly Dividend
10/03/201610:30:00Bard to Host Earnings Conference Call on October 25, 2016
09/30/201609:00:00The Medical Device Industry's Focus on Cardio and Cardiovascular...
09/29/201616:16:18Statement of Changes in Beneficial Ownership (4)
09/27/201616:07:29Statement of Changes in Beneficial Ownership (4)
09/22/201608:30:00LUTONIX® Global Real-World Registry 24-Month Outcomes Presented...
09/20/201615:26:04Statement of Changes in Beneficial Ownership (4)
09/19/201617:37:00FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee...
09/08/201609:45:24Statement of Changes in Beneficial Ownership (4)
09/08/201609:44:57Statement of Changes in Beneficial Ownership (4)
09/06/201611:00:00Bard to Present at Morgan Stanley Global Healthcare Conference
08/15/201609:57:05Initial Statement of Beneficial Ownership (3)
07/27/201610:46:19Quarterly Report (10-q)
07/26/201616:24:58Current Report Filing (8-k)
07/26/201616:15:00Bard Announces Second Quarter Results
07/06/201611:19:24Statement of Changes in Beneficial Ownership (4)
07/06/201611:19:24Statement of Changes in Beneficial Ownership (4)
07/06/201611:18:58Statement of Changes in Beneficial Ownership (4)
07/06/201611:18:58Statement of Changes in Beneficial Ownership (4)

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations